Not checkedNot checked for notices yet.
Quinacrine-CASIN combination overcomes chemoresistance in human acute lymphoid leukemia
Limei Wu, Srinivas Chatla, Qiqi Lin and 3 more
Nature Communications · 2021
doi:10.1038/s41467-021-27300-w (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Chemoresistance and relapse are main limitations in the treatment of acute lymphoblastic leukemia (ALL). Here, the authors identify Quinacrine (QC) as a sensitizer for Cytarabine (AraC) and establish a QC-CASIN regimen to improve leukemia eradication in ALL.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.